CSI Market
Sign In | Register

Effector Therapeutics Inc (EFTR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EFTR Annual Balance Sheets →
The data below summarizes Effector Therapeutics Inc's balance sheet position from Mar 31 2023 to Mar 31 2024, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/EFTR/balance-sheets
https://api.csimarket.com/api/v1/companies/EFTR/fundamentals
https://api.csimarket.com/api/v1/companies/EFTR/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2024)
(Dec 31 2023) (Sep 30 2023) (Jun 30 2023) (Mar 31 2023)
Assets
Cash & cash equivalent15.51
Short-term Investments, Total9.88
Cash & Short-term Investments24.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.87
Total Current Assets26.25
Equipment/Property/Plant Net0.19
Other Assets, Noncurrent0.69
Operating Lease Right Of Use Asset0.23
Total Assets27.13
Liabilities
Accounts Payable, Current AC1.71
Accrued Liabilities, Current AC3.79
Other Liabilities, Current20.07
Total Current Liabilities25.57
Total Long-term Debt0.00
Other liabilities, Noncurrent0.74
OperatingLeaseLiabilityNoncurrent0.18
Term Loans Net18.92
Earn Out Liability-
Operating Lease Liability Current0.05
Total Liabilities26.30
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock189.04
Retained Earnings / Accumulated Deficit-188.21
Other Equity0.00
Common Stockholder's Equity0.83
Total Stockholder's Equity0.83
Liabilities & Stockholder's Equity27.13
4 historic quarters locked

Sign in to unlock the full Effector Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Effector Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-056859

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI